Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Agric Food Chem ; 48(2): 204-12, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10691617

RESUMO

Kinetics of reduction of iron(IV) in ferrylmyoglobin by chlorogenate in neutral or moderately acidic aqueous solutions (0.16 M NaCl) to yield metmyoglobin was studied using stopped flow absorption spectroscopy. The reaction occurs by direct bimolecular electron transfer with (2.7 +/- 0.3) x 10(3) M(-)(1).s(-)(1) at 25.0 degrees C (DeltaH( )(#) = 59 +/- 6 kJ.mol(-)(1), DeltaS(#) = 15 +/- 22 J. mol(-)(1).K(-)(1)) for protonated ferrylmyoglobin (pK(a) = 4.95) and with 216 +/- 50 M(-)(1).s(-)(1) (DeltaH( )(#) = 73 +/- 8 kJ. mol(-)(1), DeltaS( )(#) = 41 +/- 30 J.mol(-)(1).K(-)(1)) for nonprotonated ferrylmyoglobin in parallel with reduction of a chlorogenate/ferrylmyoglobin complex by a second chlorogenate molecule with (8.6 +/- 1.1) x 10(2) M(-)(1).s(-)(1) (DeltaH( )(#) = 74 +/- 8 kJ.mol(-)(1), DeltaS( )(#) = 59 +/- 28 J.mol(-)(1).K(-)(1)) for protonated ferrylmyoglobin and with 61 +/- 9 M(-)(1).s(-)(1) (DeltaH( )(#) = 82 +/- 12 kJ.mol(-)(1), DeltaS( )(#) = 63 +/- 41 J. mol(-)(1).K(-)(1)) for nonprotonated ferrylmyoglobin. Previously published data on ascorbate reduction of ferrylmyoglobin are reevaluated according to a similar mechanism. For both protonated and nonprotonated ferrylmyoglobin the binding constant of chlorogenate is approximately 300 M(-)(1), and the modulation of ferrylmyoglobin as an oxidant by chlorogenate (or ascorbate) leads to a novel antioxidant interaction for reduction of ferrylmyoglobin by ascorbate in mixtures with chlorogenate.


Assuntos
Ácido Ascórbico/metabolismo , Ácido Clorogênico/metabolismo , Metamioglobina/metabolismo , Concentração de Íons de Hidrogênio , Cinética , Ligação Proteica
2.
Ugeskr Laeger ; 155(23): 1805-6, 1993 Jun 07.
Artigo em Dinamarquês | MEDLINE | ID: mdl-8317033

RESUMO

Somatostatin and the long acting somatostatin analogue Sandostatin have been shown to be effective in the management of dumping syndrome. We describe a patient with early dumping in whom this management provided total symptomatic relief. The doses was reduced from 50 micrograms to 12.5 micrograms s.c., t.i.d. At this dose clinical and biochemical parameters (blood pressure, pulse rate, packed cell volume, hematocrit, and blood glucose) were found to be within normal levels.


Assuntos
Síndrome de Esvaziamento Rápido/tratamento farmacológico , Octreotida/administração & dosagem , Adulto , Síndrome de Esvaziamento Rápido/sangue , Síndrome de Esvaziamento Rápido/fisiopatologia , Humanos , Masculino
3.
Ugeskr Laeger ; 154(25): 1785-6, 1992 Jun 15.
Artigo em Dinamarquês | MEDLINE | ID: mdl-1632021

RESUMO

A case of benign pneumoperitoneum and subcutaneous emphysema of the scrotum after elective colonoscopy with polypectomy is reported. The development and treatment of benign pneumoperitoneum is discussed.


Assuntos
Colonoscopia/efeitos adversos , Pneumoperitônio/etiologia , Escroto , Enfisema Subcutâneo/etiologia , Idoso , Humanos , Masculino , Pneumoperitônio/diagnóstico , Pneumoperitônio/terapia , Escroto/patologia , Enfisema Subcutâneo/diagnóstico , Enfisema Subcutâneo/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA